Safety Rates Drug Report: QUETIAPINE FUMARATE. Neuroleptic malignant syndrome adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: QUETIAPINE FUMARATE. Injury: Neuroleptic malignant syndrome Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 8 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
125989171	QUETIAPINE FUMARATE.	Neuroleptic malignant syndrome	APOTEX	42.00 YR	M	0	20160726	US
126068842	QUETIAPINE FUMARATE.	Neuroleptic malignant syndrome	PFIZER	49.00 YR	F	0	20160811	IT
126266311	QUETIAPINE FUMARATE.	Neuroleptic malignant syndrome	PFIZER	41.00 YR	F	0	20160805	GB
126278262	QUETIAPINE FUMARATE.	Neuroleptic malignant syndrome	TEVA	42.00 YR	M	0	20160818	US
126359832	QUETIAPINE FUMARATE.	Neuroleptic malignant syndrome	ROCHE	49.00 YR	F	0	20160822	IT
126537221	QUETIAPINE FUMARATE.	Neuroleptic malignant syndrome	ORCHID	41.00 YR	F	0	20160816	GB
126884271	QUETIAPINE FUMARATE.	Neuroleptic malignant syndrome	TEVA	49.00 YR	F	0	20160826	IT
127700041	QUETIAPINE FUMARATE.	Neuroleptic malignant syndrome	ALKEM	84.00 YR	M	0	20160922	ES

|< 1/2 << Previous Page Page 1

Total Records: 8 Number of Pages: 1

Execution Time: 0.017642021179199 seconds (ucode:5004908). Developed by: James D. Barger